KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial
Egile Nagusiak: | , , , , , , , , , , , , , , , |
---|---|
Formatua: | Conference item |
Argitaratua: |
2012
|
Gaia: |
---|